Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-16.92	121.03	145.67
Graham Fair Price	-26.49	2334.91	3176.12
PEG	-79.88	-0.21	1.06
Price/Book	-0.18	0.92	0.92
Price/Cash Flow	-84.72	2.90	19.00
Prices/Earnings	39.78	8.23	5.89
Price/Sales	-16.35	1.46	1.74
Price/FCF	-84.72	2.90	19.00
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	44.85	< 0.005	< 0.005
ROA	-40.35	< 0.005	< 0.005
ROE	0.04	0.03	-28.59
ROIC	< 0.005	< 0.005	29.39
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.29	-0.02	-1441.92
Dividends QOQ	-1.00	0.00	inf
EBIT QOQ	1.00	0.43	-57.19
EPS QOQ	0.06	-0.39	594.62
FCF QOQ	-0.83	4.68	462.91
Revenue QOQ	-0.01	0.04	193.16
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.50	0.45	-10.68
Quick Ratio	0.16	12.42	7461.08
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	3391.22	2950.14	-13.01
Cash	2883.56	2345.21	-18.67
Capex	-9.09	10.18	12.09
Free Cash Flow	163.97	932.08	468.45
Revenue	1790.36	1858.59	3.81
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	0.23	12.42	5397.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	35.71	20.11	-43.69
Naive Interpretation	Member

06 - Financial Health · Bad

Rating